跳至主要内容
临床试验/IRCT20230227057554N1
IRCT20230227057554N1尚未招募3 期

Investigating the incidence of postpartum hemorrhage in high-risk pregnant women who underwent cesarean section after the prophylactic administration of misoprostol, metrogen, and oxytocin compared to oxytocin alone

Tehran University of Medical Sciences0 个研究点目标入组 240 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
尚未招募
入组人数
240

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 40 years(—)
性别
Female

入选标准

  • Singleton term pregnant women who have an indication for termination of pregnancy (37-40 weeks).
  • Have an indication for an elective cesarean section.
  • At least one risk factor for postpartum bleeding (such as polyhydramnios, multiparity, having a history of postpartum bleeding, macrosomia, and anemia).

排除标准

  • Emergency cesarean section
  • Abnormal fetal heartbeat
  • Vaginal bleeding
  • Person with unexpected bleeding during the surgery
  • Severe anemia (hemoglobin less than 8 mg/dL) before surgery
  • Advanced underlying diseases
  • History of coagulation disorders
  • Low-lying placenta, decolman or accreta previa
  • Reaction history to the drugs

研究者

相似试验